Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 21, 2019
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized CohortNeal E Ready, Patrick A Ott, Matthew D Hellmann, et al.
Nature Medicine|January 26, 2023
Persistent mutation burden drives sustained anti-tumor immune responsesNoushin Niknafs, Archana Balan, Christopher Cherry, et al.
Cancer Research Communications|February 26, 2024
Impact of Tumor-intrinsic Molecular Features on Survival and Acquired Tyrosine Kinase Inhibitor Resistance in ALK-positive NSCLCMari Nakazawa, Guilherme Harada, Paola Ghanem, et al.
NPJ Precision Oncology|August 6, 2021
A phase I/II study of rovalpituzumab tesirine in delta-like 3-expressing advanced solid tumorsAaron S Mansfield, David S Hong, Christine L Hann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 4, 2018
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint ImmunotherapyKarthik Suresh, Kevin J Psoter, Khinh Ranh Voong, et al.
JTO Clinical and Research Reports|November 8, 2021
Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLCJoshua E Reuss, Emily Brigham, Kevin J Psoter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2022
Report of the First International Symposium on NUT CarcinomaChristopher A French, Michael L Cheng, Glenn J Hanna, et al.
Pageof 14